510(k) K936196

ANTITHROMBIN III CHROMOGENIC ASSAY by Baxter Diagnostics, Inc. — Product Code JBQ

K936196 is an FDA 510(k) premarket notification submitted by Baxter Diagnostics, Inc. for the device "ANTITHROMBIN III CHROMOGENIC ASSAY". The FDA issued a decision of Substantially Equivalent on May 4, 1994. The device falls under product code JBQ (Antithrombin Iii Quantitation), a Class II device regulated under 21 CFR 864.7060. Baxter Diagnostics, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 4, 1994
Date Received
December 29, 1993
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antithrombin Iii Quantitation
Device Class
Class II
Regulation Number
864.7060
Review Panel
HE
Submission Type